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Abstract
Background: Blood loss from the gastrointestinal tract can be an acute and life-threatening event. For the treatment
of gastrointestinal bleeding, it is important to accurately detect gastrointestinal bleeding and to localize the sites
of bleeding. The purpose of this study was to retrospectively assess the capabilities of SPECT/CT in the diagnosis
of gastrointestinal bleeding by a comparison with planar imaging alone as well as planar and SPECT.
Methods: We conducted a retrospective analysis of 20 patients (21 examinations) who underwent gastrointestinal
bleeding scintigraphy in the past 7 years and in whom the bleeding site was identified by endoscopy or capsule
endoscopy, or in whom no evidence of gastrointestinal bleeding was identified during the clinical course. Five
patients (5 examinations) were diagnosed by planar imaging (planar group). Eight patients (9 examinations) were
diagnosed by planar imaging and SPECT (planar + SPECT group). Seven patients (7 examinations) were diagnosed by
planar imaging and SPECT/CT (planar + SPECT/CT group). We calculated the diagnostic ability of each method in
detecting the presence of bleeding, as well as the ability of each method to identify the sites of bleeding. The
sensitivity, specificity, and accuracy of the methods were compared.
Results: The diagnostic ability of the three imaging methods in detecting the presence of gastrointestinal
bleeding was as follows. Planar imaging showed 100% sensitivity (3/3), 100% specificity (2/2), and 100%
accuracy (5/5). Planar + SPECT imaging showed 85.7% sensitivity (6/7), 100% specificity (2/2), and 88.9%
accuracy (8/9). Planar + SPECT/CT imaging showed 100% sensitivity (6/6), 100% specificity (1/1), and 100%
accuracy (7/7). The diagnostic ability of the three modalities in detecting the site of bleeding was as follows: planar, 33.
3% (1/3); planar + SPECT, 71.4% (5/7); and planar + SPECT/CT, 100% (6/6).
Conclusions: All 3 imaging methods showed good accuracy in detecting the presence of gastrointestinal
bleeding. The addition of SPECT or SPECT/CT made the anatomical position of the uptake clear and contributed
to the localization of the site of gastrointestinal bleeding. Planar + SPECT/CT imaging therefore showed the highest
diagnostic ability for detecting the site of gastrointestinal bleeding.
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Background
Gastrointestinal bleeding is a problem commonly en-
countered in the clinical setting. In most cases, bleed-
ing will stop spontaneously without any intervention;
however, blood loss from the gastrointestinal tract
can represent an acute and life-threatening event. Ob-
scure gastrointestinal bleeding (OGIB) is defined as
bleeding of unknown origin that persists or recurs after an
initial negative endoscopic evaluation, including upper
and lower endoscopy. OGIB can be classified as overt
or occult OGIB. Overt OGIB refers to recurrent or per-
sistent visible bleeding (hematochezia, melena or hema-
temesis), and occult OGIB is defined as recurrent or
persistent iron deficiency and/or positive fecal occult
blood [1, 2].
For the treatment of gastrointestinal bleeding, it is ne-
cessary to localize the bleeding site. Although methods
of identifying the bleeding site vary, endoscopy is usually
performed to localize the site. Other methods include
angiography, computed tomography (CT), capsule en-
doscopy and scintigraphy. Angiography has the advan-
tage of therapeutic intervention through transcatheter
embolization, but cannot detect bleeding at a rate of <
1.0 ml/min [3, 4]. Intermittent bleeding is difficult to de-
tect by angiography [5]. The accuracy of the angiography
in detecting the site of bleeding is reported to range
from 43 to 87% [6, 7]. Contrast enhanced CT is used to
detect gastrointestinal bleeding. The extravasation of
contrast agent into the bowel lumen generally represents
bleeding. If bleeding is not active or is intermittent at
the time of imaging, the usefulness of this method is
limited [8]. In a study using a swine model, a colonic
bleeding rate of 0.3 ml/min was detectable on contrast
enhanced CT [9]. Capsule endoscopy revolutionized the
examination of the small intestine, and has been estab-
lished as one of the procedures used to diagnose small
intestine bleeding [10, 11]; the diagnostic yield is 40–
60% [12, 13].
Bleeding scintigraphy is a nuclear medicine imaging
examination that does not require bowel preparation
and enables the detection of gastrointestinal bleeding
with a bleeding rate as low as 0.1–0.5 ml/min [1, 12]. In
this examination, a radioisotope is injected intraven-
ously. This method is safe and minimally invasive and al-
lows for continuous monitoring over several hours,
which is a major advantage over other diagnostic
methods. In addition to Tc-99 m-labeled red blood
cells (Tc-99 m RBCs), Tc-99 m human serum albumin-
diethylenetriaminepentaacetic acid (Tc-99m HSA-DTPA)
has been widely used in gastrointestinal bleeding scintig-
raphy [14–16]. Scintigraphy with Tc-99 m HSA-DTPA
is a blood pooling method similar to scintigraphy with
Tc-99m RBCs. Tc-99m HSA-DTPA is stable in blood and
does not generate free Tc-99m.
The addition of single-photon emission computed
tomography/computed tomography (SPECT/CT) to pla-
nar imaging on gastrointestinal bleeding scintigraphy
can help to identify the site of gastrointestinal bleeding
[14, 17]. To date, no studies have compared the diagnos-
tic ability of planar + SPECT/CT imaging and planar +
SPECT imaging. Thus, in the present study, we calcu-
lated the diagnostic ability of each method for detecting
the presence of bleeding as well as the ability of each
method to identify the sites of bleeding. The sensitivity,
specificity, and accuracy of the methods were compared.
Methods
Patients
Twenty patients who underwent a total of 21 scintigraphic
examinations because of gastrointestinal bleeding over the
9-year period from March 2007 to September 2015 were
retrospectively included in the study. The bleeding site
was identified by endoscopy (n = 11), capsule endoscopy
(n = 2) or contrast-enhanced CT (n = 2), or else no evi-
dence of gastrointestinal bleeding was identified during
the clinical course (n = 5). The study group comprised 9
female patients and 11 males (mean age ± standard devi-
ation [SD] = 65.7 ± 18.1 years; range 16–85 years). Among
the 20 patients of the study group, 45% (n = 9) had overt
OGIB, and 45% (n = 9) patients had occult OGIB. The
remaining 10% (n = 2) were not classified with regard to
OGIB because they did not undergo endoscopic examina-
tions. In five patients, only planar imaging was performed.
These patients were therefore defined as the planar group.
In eight patients, planar and SPECT imaging were per-
formed. One of these patients was examined twice using
this method. These patients were therefore defined as the
planar + SPECT group. In seven patients, planar and
SPECT/CT imaging were performed. These patients were
therefore defined as the planar + SPECT/CT group. We
retrospectively reviewed the gastrointestinal bleeding scin-
tigraphy of the 20 patients (21 scintigraphy examinations)
to investigate the diagnostic ability of the three imaging
modalities. This retrospective study was approved by the
institutional review board, which waived the requirement
for written informed consent.
Scanning and data acquisition for gastrointestinal
bleeding scintigraphy
All patients were injected with Tc-99 m HSA-DTPA
(Nihon Medi-Physics Co. Ltd., Tokyo, Japan) through
the peripheral vein. Planar images of the anterior and
posterior sides of the abdomen and pelvis were ac-
quired. Initially, 64 frames were obtained consecutively
for blood perfusion phase dynamic imaging at a rate of
2 s/frame (matrix size, 128 × 128 pixels). After blood
perfusion phase dynamic imaging, static imaging was
performed at 10, 20, 30, 40, 50, 60 min, and 3, 6, 24 h
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(matrix size, 256 × 256 pixels). SPECT data were ob-
tained when an abnormal uptake of RI was suspected
based on the planar imaging findings. When an abnor-
mal uptake of RI was not detected on planar imaging,
SPECT data were obtained at 6 h and 24 h. SPECT data
were acquired for the region of interest (matrix size,
128 × 128 pixels, 6° angle steps, 20 s/frame). The acqui-
sition parameters for CT were as follows: 130 keV, pitch
1.0, rotation time 0.6 s, and slice thickness 5.0 mm.
The planar group and the planar + SPECT group
A dual-head gamma camera (E.CAM, Toshiba Medical
Systems Corporation, Otawara, Japan) with a low-energy
high-resolution (LEHR) collimator was used in the pla-
nar group and the planar + SPECT group.
Planar + SPECT/CT group
A SPECT/CT system (Symbia T16, Siemens Medical So-
lutions, Erlangen, Germany) with a LEHR collimator was
used in the planar + SPECT/CT group.
Evaluation of gastrointestinal bleeding scintigraphy
The 21 scintigraphy examinations of the 20 patients
were interpreted by two board-certificated nuclear medi-
cine physicians. Two physicians specializing in nuclear
medicine performed the interpretation and all final judg-
ments were made by consensus. We evaluated the ability
of detecting the presence of bleeding and the ability of
identifying the bleeding sites.
Statistical methods
The quantitative variables were expressed as mean ±
standard deviation (SD) with the ranges. The normal-
ity of distribution of the variables was tested by the
Levene test. A one-way analysis of variance (normal
distribution) or the Kruskal-Wallis test (non-normal
distribution) was applied to evaluate differences in pa-
rameters. The SPSS Statistics software program (ver-
sion 24, IBM, Chicago, IL, USA) was used to perform
the statistical analyses. P values of < 0.05 were consid-
ered to indicate statistical significance.
Results
The clinical characteristics of the patients in the present
study are shown in Table 1. The bleeding site was identi-
fied in 16/21 (76.2%) examinations. The bleeding site
was identified in 3/5 (60%) examinations in the planar
group, 7/9 (77.8%) examinations in the planar + SPECT
group, and 6/7 (85.7%) examinations in the planar +
SPECT/CT group. No bleeding sites were identified in
the other 5 examinations. The sites and causes of bleed-
ing are shown in Table 2. The bleeding sites in the 16
examinations included the small intestine (n = 9), ascend-
ing colon (n = 2), stomach (n = 2), rectum/anus (n = 1) and
Table 1 The clinical characteristics of the study group (n = 21)
Planar (n = 5) Planar + SPECT (n = 9) Planar + SPECT/CT (n = 7) p value
Age 59.4 ± 23.6 63.6 ± 20.9 71.6 ± 8.8 0.512
Gender (male) 3 (60%) 5 (56%) 3 (43%) 0.838
Blood test
Hgb (g/dl) 7.8 ± 1.5 8.7 ± 2.0 9.2 ± 1.7 0.429
Hct (%) 23.5 ± 4.3 27.3 ± 6.4 28.8 ± 4.5 0.268
Plt (× 103/μl) 286 ± 73 211 ± 127 290 ± 103 0.426
BUN (mg/dl) 40.4 ± 44.7 16.9 ± 6.3 18.0 ± 4.3 0.494
Cre (mg/dl) 1.65 ± 2.30 0.83 ± 0.24 1.05 ± 0.57 0.896
Drug use
NSAIDs 1 2 4
Steroid 3 3 1
Antiplatelet drug 0 2 2
Anticoagulant 1 3 0
Past medical history
Renal failure 1 0 3
Heart failure 1 2 0
Liver cirrhosis 1 0 2
Malignancy 2 5 4
Post gastrointestinal op. status 2 3 4
Inflammatory bowel disease 1 1 0
Hgb Hemoglobin, Hct Hematocrit, Plt Platelets, BUN Blood urea nitrogen, Cre Serum creatinine, NSAIDs Nonsteroidal anti-inflammatory drugs
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extra-gastrointestinal tube (n = 2). The causes of bleed-
ing in the 16 examinations included ulcer (n = 5; small
intestine [n = 4], colon [n = 1]), vascular ectasia (n = 3),
metastatic carcinoma (n = 2), rupture of varices (n = 2),
diverticulum (n = 1), fistula (n = 1) and extra-gastrointestinal
lesions (n = 2; subcutaneous hematoma [n = 1], rupture
of aneurysm [n = 1]).
The diagnostic ability of the three methods in detecting
the presence of gastrointestinal bleeding was as follows.
The planar group showed 100% sensitivity (3/3), 100%
specificity (2/2), a PPV of 100% (3/3), an NPV of 100% (2/
2), and 100% accuracy (5/5). The planar + SPECT group
showed 85.7% sensitivity (6/7), 100% specificity (2/2), a
PPV of 100% (6/6), an NPV of 66.7% (2/3), and 88.9% ac-
curacy (8/9). The planar + SPECT/CT group showed 100%
sensitivity (6/6), 100% specificity (1/1), a PPV of 100% (6/6),
an NPV of 100% (1/1), and 100% accuracy (7/7) (Table 3).
The diagnostic ability of planar, planar + SPECT and
planar + SPECT/CT in detecting the site of bleeding
was 33.3% (1/3), 71.4% (5/7) and 100% (6/6), respect-
ively (Table 4). Figure 1 show a representative patient
in whom both the presence and site of bleeding was
detected by planar + SPECT/CT.
In the planar images, we found an abnormally increased
uptake that indicated bleeding on early images (< 60min
after RI injection) in 11/16 (68.8%) examinations, and on
delayed images (> 180min after RI injection) in 4/16
(25.0%) examinations. Another 1 examination was a
false-negative (Table 5).
Discussion
The most common bleeding site was the small intestine
and most common cause of bleeding was ulcer. There
were two examinations in which the site of bleeding was
located outside the gastrointestinal tube. One involved a
lumbar subcutaneous huge hematoma and the other in-
volved the intraperitoneal rupture of a left gastric artery
aneurysm. Gastrointestinal bleeding scintigraphy images
of the 2 examinations showed an abnormally increased
uptake and positivity for bleeding; however, we mis-
judged the bleeding site in the case involving the intra-
peritoneal rupture of a left gastric artery aneurysm,
which was in the planar group. Gastrointestinal bleeding
scintigraphy could detect bleeding outside of the gastro-
intestinal tube.
We would thus like to emphasize that an abnormally
increased uptake, which indicated bleeding, was detected
in the early images of most examinations. Schillaci et al.
reported that an abnormal uptake indicating bleeding
was detected in early images (< 90min after RI injection)
in 18 of 20 patients (90%) [17]. Because an abnormal up-
take indicating bleeding was detected earlier in most
cases, special care should be taken in the interpretation
of early images.
All 3 groups (planar group, planar + SPECT group,
planar + SPECT/CT group) showed good accuracy in
detecting the presence of gastrointestinal bleeding.
Kotani et al. reported that the accuracy of planar im-
aging in detecting bleeding was high as 83% [14]. Al-
though each of the imaging methods was good for
detecting the presence of gastrointestinal bleeding, not
all these methods were good for detecting the site of
bleeding. In the present study, the planar group showed
low diagnostic ability (33.3%) in detecting the site of
bleeding. The diagnostic ability of the planar + SPECT
group (71.4%) was superior to that of the planar group.
Olds et al. reported that the accuracy of planar images
on Tc-99m-RBC scintigraphy in detecting the site of
bleeding was 48% [18], while Schillaci et al. reported that
the accuracy of planar images on Tc-99 m-RBC scintig-
raphy in detecting the site of bleeding was 42.8% [17].
There are some case reports that additional SPECT
images of gastrointestinal bleeding scintigraphy were
useful for localizing the site of bleeding [16, 19, 20];
however, few studies have focused on the comparison of
SPECT to planar gastrointestinal bleeding scintigraphy.
In our study, planar + SPECT was superior to planar im-
aging in detecting the site of bleeding. Because add-
itional SPECT images provide more information than
Table 2 The sites and causes of bleeding
Sites Causes
Small intestine 9 Ulcer 5
Ascending colon 2 Vascular ectasia 3
Stomach 2 Metastatic carcinoma 2
Rectum/Anus 1 Rupture of varices 2
Diverticulum 1
Fistula 1
Extra-gastrointestinal tube 2 Subcutaneous hematoma 1
Rupture of aneurysm 1
Table 3 The diagnostic ability in detecting the presence of bleeding
Sensitivity Specificity PPV NPV Accuracy
Planar group (n = 5) 100% (3/3) 100% (2/2) 100% (3/3) 100% (2/2) 100% (5/5)
Planar + SPECT group (n = 9) 85.7% (6/7) 100% (2/2) 100% (6/6) 66.7% (2/3) 88.9% (8/9)
Planar + SPECT/CT group (n = 7) 100% (6/6) 100% (1/1) 100% (6/6) 100% (1/1) 100% (7/7)
PPV Positive predictive value, NPV Negative predictive value
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anatomic cross-sectional imaging modalities such as CT,
the additional performance of SPECT can help to iden-
tify the site of gastrointestinal bleeding.
In the previous articles that compared SPECT/CT to
planar gastrointestinal bleeding scintigraphy, planar +
SPECT/CT was superior to planar imaging in detecting
the site of bleeding. The accuracy of planar + SPECT/
CT in the localization of gastrointestinal bleeding site
was reported to be 78%, while that of planar imaging
was 50% [14]. No articles have compared SPECT to
SPECT/CT. Our study was the first to compare the
diagnostic ability of SPECT/CT with that of SPECT. In
evaluating gastrointestinal bleeding scintigraphy in
daily medical practice, we interpret both planar image
and SPECT or SPECT/CT image. Planar image can
demonstrate entire abdomen and pelvis, and SPECT or
SPECT/CT can show anatomical location of bleeding
site in more detail. Therefore, we compared planar +
SPECT/CT with planar + SPECT.
Although the detectability of the bleeding site in the
planar group was low (33.3%), the detectability in the
planar + SPECT and planar + SPECT/CT groups was
high (71.4 and 100%, respectively). With the addition of
SPECT or SPECT/CT, the anatomical position of the
uptake becomes clear. In particular, planar + SPECT/CT
imaging showed the highest diagnostic ability of the
three methods in detecting the site of gastrointestinal
bleeding.
This study has a few limitations. First, this study was
performed in a single institution, and relatively few
cases were evaluated. Given that the limited data cur-
rently available might have resulted in some inaccur-
acies in our findings, further studies in a larger series of
cases is required to more fully elucidate the clinical ad-
vantages of SPECT/CT for the diagnosis of gastrointes-
tinal bleeding. Second, the series of gastrointestinal
bleeding disease includes deflection because this is a
retrospective study. Third, the endoscopic exams per-
formed varied among cases. A fourth limitation relates
to the absence of a comparison with CT angiography,
which has demonstrated high degrees of accuracy for
the diagnosis of active gastrointestinal bleeding, and
with CT-enteroclysis, which has demonstrated high de-
grees of accuracy for the diagnosis of obscure gastro-
intestinal bleeding [2, 21–23]. However, despite these
limitations, the present study is the first time compared
planar + SPECT/CT of gastrointestinal bleeding scin-
tigraphy with planar + SPECT in detecting the bleeding
site. Our study was the first that compare the diagnos-
tic ability of SPECT/CT with SPECT.
Table 4 The diagnostic ability in detecting the site of bleeding
No. of
correctly
identified
bleeding sites
No. of
incorrectly
identified
bleeding sites
Accuracy
Planar group
(n = 3)
1 2 33.3% (1/3)
Planar + SPECT group
(n = 7)
5 2 71.4% (5/7)
Planar + SPECT/CT group
(n = 6)
6 0 100% (6/6)
Fig. 1 Planar + SPECT/CT of the representative patient where the site of bleeding could be detected. Planar images (a 3 h after radioisotope
injection, b 6 h after, c 24 h after) and SPECT/CT images (d SPECT, e CT, f SPECT/CT, 6 h after radioisotope injection). No abnormal uptake was
noted in planar images at 3 h after radioisotope injection (a). A spotty uptake was seen in the right lower abdomen in planar images at 6 h
after the injection (arrow) (b). In the planar images at 24 h after the injection, a diffuse uptake was seen in the ascending and descending
colon (arrowheads) (c). In SPECT/CT images at 6 h after the injection, the spotty uptake matched the distant jejunum (d, e and f) (arrows). It
was revealed to be small intestinal metastasis of colon cancer
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Conclusion
In the three groups (planar group, planar + SPECT
group, planar + SPECT/CT group) examinations showed
high degrees of accuracy in detecting the presence of
gastrointestinal bleeding. Moreover, our results indicate
that planar + SPECT/CT imaging has higher diagnostic
ability for detecting the site of gastrointestinal bleeding
than the other two methods. Therefore, we conclude
that gastrointestinal bleeding scintigraphy using plane +
SPECT/CT images might be more useful for determin-
ing the treatment plan of gastrointestinal bleeding than
the other two methods.
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